Table 2

The proliferation and apoptosis of the pancreatic cancer cell line
Group G0-G1 (%) S (%) G2-M (%) PI (%) AI (%)
110-nm GEM-ANPs 45.8 43.6 10.6 54.2 ± 8.7* 3.6 ± 1.5*
406-nm GEM-ANPs 44.0 48.5 7.5 56.0 ± 8.1* 6.3 ± 1.2*
Gemcitabine 35.3 46.5 18.2 64.67 ± 6.4 3.74 ± 0.4*
ANPs 25.9 55.4 18.8 74.11 ± 3.6 2.56 ± 0.1
Control 28.6 53.6 17.9 71.46 ± 4.8 1.78 ± 0.7

After exposure to 0.1 μg/mL of different samples for 72 h, analyzed by flow cytometry technique (n = 5). *Significant difference compared with both control group and ANP group, p < 0.05.

Li et al.

Li et al. Nanoscale Research Letters 2013 8:176   doi:10.1186/1556-276X-8-176

Open Data